Results 71 to 80 of about 104,116 (405)

Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018

open access: yesAddiction Science & Clinical Practice, 2022
Background Medications to treat opioid use disorder (OUD) including buprenorphine products are evidence-based and cost-effective tools for combating the opioid crisis.
Kevin P. Conway   +5 more
doaj   +1 more source

Neurobehavioral consequences of chronic intrauterine opioid exposure in infants and preschool children: a systematic review and meta-analysis [PDF]

open access: yes, 2014
<b>Background</b><p></p> It is assumed within the accumulated literature that children born of pregnant opioid dependent mothers have impaired neurobehavioral function as a consequence of chronic intrauterine opioid use.<p>&
A Baldacchino   +86 more
core   +15 more sources

Transition from methadone to subcutaneous buprenorphine depot in patients with opioid use disorder - a case report

open access: yesEuropean Psychiatry
Introduction Opioid dependence is a complex condition that often requires long-term treatment and care. Methadone, a synthetic full opioid agonist, and buprenorphine, a partial agonist at the opioid receptor, are most commonly used for substitution ...
M. Delic
doaj   +1 more source

Stigma as a fundamental hindrance to the United States opioid overdose crisis response. [PDF]

open access: yes, 2019
Alexander Tsai and co-authors discuss the role of stigma in responses to the US opioid ...
Barnett, Michael L   +9 more
core   +2 more sources

Trends in Buprenorphine Treatment in the United States, 2009-2018.

open access: yesJournal of the American Medical Association (JAMA), 2020
This study assessed the number of individuals receiving treatment for opioid use disorder in the United States by age group and sex using a national prescription database to compare between the number of buprenorphine prescriptions filled and the number ...
M. Olfson   +3 more
semanticscholar   +1 more source

Adaptation of the Tele-Harm Reduction intervention to promote initiation and retention in buprenorphine treatment among people who inject drugs: a retrospective cohort study

open access: yesAnnals of Medicine, 2023
Background: At the start of the pandemic, relaxation of buprenorphine prescribing regulations created an opportunity to create new models of medications for opioid use disorder (MOUD) delivery and care.
Edward Suarez   +9 more
doaj   +1 more source

Ethanol reversal of tolerance to the respiratory depressant effects of morphine [PDF]

open access: yes, 2015
Opioids are the most common drugs associated with unintentional drug overdose. Death results from respiratory depression. Prolonged use of opioids results in the development of tolerance but the degree of tolerance is thought to vary between different ...
A Fugelstad   +62 more
core   +3 more sources

3D Bioprinting of Thick Adipose Tissues with Integrated Vascular Hierarchies

open access: yesAdvanced Functional Materials, Volume 35, Issue 12, March 18, 2025.
An advanced 3D bioprinting technique is used here to create thick adipose tissues with a central, vessel and extensive branching. The construct is made using alginate, gelatin and collagen‐based bioinks. Flow through the complex vessel network is demonstrated as well as its successful integration with a femoral artery following implantation in a rat ...
Idit Goldfracht   +5 more
wiley   +1 more source

Low-dose buprenorphine initiation during pregnancy: a case report

open access: yesAJOG Global Reports
Buprenorphine is recommended for pregnant patients with opioid use disorder. Traditional buprenorphine initiation requires moderate withdrawal symptoms to prevent precipitating withdrawal.
Shivania Reddy, BSc   +1 more
doaj   +1 more source

Barriers To Recovery For Bangor\u27s Buprenorphine Patients [PDF]

open access: yes, 2015
There are several buprenorphine providers at EMMc\u27s Center for Family Medicine serving the greater Bangor, ME region - an area of substantial opiate use.
Keller, Erin, McLaren, John R
core   +1 more source

Home - About - Disclaimer - Privacy